Cargando…
CRISPR-Cas9: from Genome Editing to Cancer Research
Cancer development is a multistep process triggered by innate and acquired mutations, which cause the functional abnormality and determine the initiation and progression of tumorigenesis. Gene editing is a widely used engineering tool for generating mutations that enhance tumorigenesis. The recent d...
Autores principales: | Chen, Si, Sun, Heng, Miao, Kai, Deng, Chu-Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5166485/ https://www.ncbi.nlm.nih.gov/pubmed/27994508 http://dx.doi.org/10.7150/ijbs.17421 |
Ejemplares similares
-
CRISPR/Cas9 genome editing approaches for psychiatric research
por: Gutiérrez-Rodríguez, Araceli, et al.
Publicado: (2023) -
CRISPR/Cas9-mediated genome editing in nonhuman primates
por: Kang, Yu, et al.
Publicado: (2019) -
Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021) -
Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
por: Zhao, Ziyi, et al.
Publicado: (2021) -
CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy
por: Ding, Shuai, et al.
Publicado: (2023)